BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 29191651)

  • 1. Molecular Interactions of a DNA Modifying Enzyme APOBEC3F Catalytic Domain with a Single-Stranded DNA.
    Fang Y; Xiao X; Li SX; Wolfe A; Chen XS
    J Mol Biol; 2018 Jan; 430(1):87-101. PubMed ID: 29191651
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The in vitro Biochemical Characterization of an HIV-1 Restriction Factor APOBEC3F: Importance of Loop 7 on Both CD1 and CD2 for DNA Binding and Deamination.
    Chen Q; Xiao X; Wolfe A; Chen XS
    J Mol Biol; 2016 Jul; 428(13):2661-70. PubMed ID: 27063502
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Crystal structure of DNA cytidine deaminase ABOBEC3G catalytic deamination domain suggests a binding mode of full-length enzyme to single-stranded DNA.
    Lu X; Zhang T; Xu Z; Liu S; Zhao B; Lan W; Wang C; Ding J; Cao C
    J Biol Chem; 2015 Feb; 290(7):4010-21. PubMed ID: 25542899
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of the DNA sequence/length and pH on deaminase activity, as well as the roles of the amino acid residues around the catalytic center of APOBEC3F.
    Wan L; Nagata T; Katahira M
    Phys Chem Chem Phys; 2018 Jan; 20(5):3109-3117. PubMed ID: 28825755
    [TBL] [Abstract][Full Text] [Related]  

  • 5. APOBEC3G Interacts with ssDNA by Two Modes: AFM Studies.
    Shlyakhtenko LS; Dutta S; Banga J; Li M; Harris RS; Lyubchenko YL
    Sci Rep; 2015 Oct; 5():15648. PubMed ID: 26503602
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DNA mutagenic activity and capacity for HIV-1 restriction of the cytidine deaminase APOBEC3G depend on whether DNA or RNA binds to tyrosine 315.
    Polevoda B; Joseph R; Friedman AE; Bennett RP; Greiner R; De Zoysa T; Stewart RA; Smith HC
    J Biol Chem; 2017 May; 292(21):8642-8656. PubMed ID: 28381554
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An insight into the dependence of the deamination rate of human APOBEC3F on the length of single-stranded DNA, which is affected by the concentrations of APOBEC3F and single-stranded DNA.
    Wan L; Kamba K; Nagata T; Katahira M
    Biochim Biophys Acta Gen Subj; 2020 Feb; 1864(2):129346. PubMed ID: 30986508
    [TBL] [Abstract][Full Text] [Related]  

  • 8. APOBEC3F and APOBEC3G inhibit HIV-1 DNA integration by different mechanisms.
    Mbisa JL; Bu W; Pathak VK
    J Virol; 2010 May; 84(10):5250-9. PubMed ID: 20219927
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Crystal Structure of a Soluble APOBEC3G Variant Suggests ssDNA to Bind in a Channel that Extends between the Two Domains.
    Maiti A; Myint W; Delviks-Frankenberry KA; Hou S; Kanai T; Balachandran V; Sierra Rodriguez C; Tripathi R; Kurt Yilmaz N; Pathak VK; Schiffer CA; Matsuo H
    J Mol Biol; 2020 Nov; 432(23):6042-6060. PubMed ID: 33098858
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of conserved motifs in HIV-1 Vif required for APOBEC3G and APOBEC3F interaction.
    He Z; Zhang W; Chen G; Xu R; Yu XF
    J Mol Biol; 2008 Sep; 381(4):1000-11. PubMed ID: 18619467
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Crystal structure of the anti-viral APOBEC3G catalytic domain and functional implications.
    Holden LG; Prochnow C; Chang YP; Bransteitter R; Chelico L; Sen U; Stevens RC; Goodman MF; Chen XS
    Nature; 2008 Nov; 456(7218):121-4. PubMed ID: 18849968
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Crystal structure of the catalytic domain of HIV-1 restriction factor APOBEC3G in complex with ssDNA.
    Maiti A; Myint W; Kanai T; Delviks-Frankenberry K; Sierra Rodriguez C; Pathak VK; Schiffer CA; Matsuo H
    Nat Commun; 2018 Jun; 9(1):2460. PubMed ID: 29941968
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Catalytic analysis of APOBEC3G involving real-time NMR spectroscopy reveals nucleic acid determinants for deamination.
    Kamba K; Nagata T; Katahira M
    PLoS One; 2015; 10(4):e0124142. PubMed ID: 25875164
    [TBL] [Abstract][Full Text] [Related]  

  • 14. APOBEC3G and APOBEC3F Act in Concert To Extinguish HIV-1 Replication.
    Krisko JF; Begum N; Baker CE; Foster JL; Garcia JV
    J Virol; 2016 May; 90(9):4681-4695. PubMed ID: 26912618
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanism for APOBEC3G catalytic exclusion of RNA and non-substrate DNA.
    Solomon WC; Myint W; Hou S; Kanai T; Tripathi R; Kurt Yilmaz N; Schiffer CA; Matsuo H
    Nucleic Acids Res; 2019 Aug; 47(14):7676-7689. PubMed ID: 31424549
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Single-stranded DNA scanning and deamination by APOBEC3G cytidine deaminase at single molecule resolution.
    Senavirathne G; Jaszczur M; Auerbach PA; Upton TG; Chelico L; Goodman MF; Rueda D
    J Biol Chem; 2012 May; 287(19):15826-35. PubMed ID: 22362763
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of two distinct human immunodeficiency virus type 1 Vif determinants critical for interactions with human APOBEC3G and APOBEC3F.
    Russell RA; Pathak VK
    J Virol; 2007 Aug; 81(15):8201-10. PubMed ID: 17522216
    [TBL] [Abstract][Full Text] [Related]  

  • 18. APOBEC3DE Antagonizes Hepatitis B Virus Restriction Factors APOBEC3F and APOBEC3G.
    Bouzidi MS; Caval V; Suspène R; Hallez C; Pineau P; Wain-Hobson S; Vartanian JP
    J Mol Biol; 2016 Aug; 428(17):3514-28. PubMed ID: 27289067
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Signals in APOBEC3F N-terminal and C-terminal deaminase domains each contribute to encapsidation in HIV-1 virions and are both required for HIV-1 restriction.
    Song C; Sutton L; Johnson ME; D'Aquila RT; Donahue JP
    J Biol Chem; 2012 May; 287(20):16965-74. PubMed ID: 22451677
    [TBL] [Abstract][Full Text] [Related]  

  • 20. RNA-binding residues in the N-terminus of APOBEC3G influence its DNA sequence specificity and retrovirus restriction efficiency.
    Bélanger K; Langlois MA
    Virology; 2015 Sep; 483():141-8. PubMed ID: 25974865
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.